MedTrace Logo

A Reduction in Time With Electronic Monitoring In Stroke

NCT02808806 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-09-30

No results posted yet for this study

Summary

The purpose of the ARTEMIS trial is to investigate if real-time feedback to caregivers reduces the time between patient's first medical contact and start of intravenous thrombolysis and/or intraarterial thrombectomy in patients with acute ischemic stroke.

Conditions

  • Acute Ischemic Stroke
  • Stroke

Interventions

OTHER

real-time audio-visual feedback

real-time audio-visual feedback to caregivers on TSD (i.e. displaying time, a colour code which will provide an easy-view visualization on whether or not pre-set median time delays between locations are exceeded, and auditory signals indicating the elapsed time), displayed through handhelds and on pre-mounted tablets through the whole trajectory of acute stroke care

Sponsors & Collaborators

  • The Dutch Brain Foundation

    collaborator OTHER

  • Innovation Fund Healthcare Insurers, the Netherlands

    collaborator UNKNOWN

  • Leiden University Medical Center

    collaborator OTHER

  • Leiden University

    lead OTHER

Principal Investigators

  • Nyika D Kruyt, MD PhD · Leiden University Medical Center

  • Marieke JH Wermer, MD PhD · Leiden University Medical Center

  • Ale Algra, MD, professor · Leiden University Medical Center, the Netherlands. The Julius Centre, University Medical Centre Utrecht, The Netherlands.

  • Yvo BWEM Roos, MD, professor · Academical Medical Center, the Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2020-01-01
Completion
2020-03-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02808806 on ClinicalTrials.gov